| Financial Year |
March 31 2023 |
| Monetary Funds |
295,278,382.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,071.90 |
| Accounts Receivable |
125,915,235.28 |
| Advances to Suppliers |
66,858,817.53 |
| Other Receivables |
12,127,340.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,091,207.06 |
| Inventories |
261,974,804.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,234,178.66 |
| Total Current Assets |
763,419,831.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
191,480,672.42 |
| Investment Properties |
-- |
| Fixed Assetes |
259,292,288.67 |
| Under-construction Projects |
5,966,384.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,164,866.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,079,419.60 |
| Deferred Income Tax Assets |
5,953,222.88 |
| Other Non-Current Assets |
16,349,093.25 |
| Sub-Total of Non-Current Assets |
498,756,528.31 |
| Total Assets |
1,262,176,359.78 |
| Short-Term Loans |
55,067,756.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,946,871.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,772,480.36 |
| Taxes Payable |
8,417,616.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,033,290.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,984,647.97 |
| Other Current Liabilities |
3,893,494.80 |
| Sub-Total of Current Liabilities |
207,577,643.39 |
| Long-term Loans |
12,351,750.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,593,222.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,305,069.85 |
| Total Liabilities |
238,882,713.24 |
| Paid-In Capital(Or Share Stock) |
832,000,000.00 |
| Capital Surplus |
1,965,785.45 |
| Surplus Reserve |
48,001,953.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
216,208,193.84 |
| Minority Stockholder's Interest |
3,877,769.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,019,415,877.08 |
| Owner's Equity（Stockholder's Equity） |
1,023,293,646.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,262,176,359.78 |
